1. Intravitreal Injection of Bevacizumab in Eales Disease.
- Author
-
Küçükerdönmez, Cem, Akova, Yonca A., and Yilmaz, Gürsel
- Subjects
- *
BEVACIZUMAB , *ANTINEOPLASTIC agents , *EYE diseases , *RETINAL diseases , *FLUORESCENCE angiography - Abstract
Purpose: To report a case of presumed Eales disease that showed regression of retinal neovascularization after the use of intravitreal bevacizumab. Design: Retrospective, interventional case report. Methods: Broad retinal neovascularization in a patient with presumed Eales disease did not regressed despite adequate photocoagulation treatment, and bevacizumab (1.25 mg) was injected intravitreally. The patient was followed up for 1 year. Results: One week after injection, fluorescein angiography demonstrated dramatic regression of retinal neovascularization. After 12-months, visual acuity was improved and no signs of recurrence were observed. Conclusion: Intravitreal bevacizumab may be effective as an adjunctive treatment of retinal neovascularization in patients with Eales disease. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF